All lobbying filings

TWENTY-FIRST CENTURY GROUP, INC.

Lobbying for NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX) · Pharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · Senate · $24,000.00 income · posted Apr 17, 2026

Official filing document

Lobbying activity 4

Health Issues

Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.

Medical/Disease Research/Clinical Labs

Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.

Veterans

Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.

Budget/Appropriations

Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD within the Fiscal Year 2027 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Bill.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.